Pre-Employment, Random and Post-Accident Testing

"I have a drug test" can mean a lot of different things depending on why the test is happening, who's requiring it, and what rules apply. That context changes almost everything about what to expect. Here's how the main categories break down.

The situations that trigger a test

Pre-employment. A test required as a condition of being hired, usually after a conditional job offer and before a start date. This is the most common type most people encounter, and it's typically scheduled with advance notice.

Random. Testing selected by an unpredictable method from a pool of employees, with no individualized suspicion required. Under federal transportation rules, random selection has to be scientifically valid — essentially, a method that gives every covered employee an equal chance of being picked at any time — and employers have to test at minimum annual rates the regulations specify.

Reasonable suspicion. Triggered by specific, documented observations from a trained supervisor — signs like odor, behavior, or appearance that suggest possible impairment. This isn't a random or scheduled event; it requires a supervisor to have and document a specific basis for the referral.

Post-accident. Testing after a workplace accident that meets specific criteria, such as a fatality or certain thresholds of injury or vehicle damage in DOT-regulated settings. Post-accident testing exists to establish what was or wasn't a factor at the time of an incident, which is part of why it's held to strict timing requirements — waiting too long undermines the whole point of the test.

Return-to-duty and follow-up. After a verified positive, refusal, or other rule violation, an employee in many regulated programs has to complete a return-to-duty process — including evaluation by a substance abuse professional — before resuming safety-sensitive duties, often followed by a period of unannounced follow-up testing.

Private employers outside regulated industries can structure their own policies differently, and state law varies on what's permitted. The categories above describe common patterns, not a universal rulebook — your own employer's policy is the one that actually governs your situation.

Who's covered by federal DOT rules

Not every job with a drug test falls under federal transportation rules. The Department of Transportation's testing procedures, set out in 49 CFR Part 40, apply specifically to safety-sensitive employees in DOT-regulated industries: commercial drivers, aviation personnel, railroad workers, pipeline workers, transit employees, and merchant mariners, among others, each governed by rules from their specific DOT operating administration.

For commercial motor vehicle drivers specifically, coverage is defined in 49 CFR Part 382: broadly, anyone who operates a commercial motor vehicle with a gross vehicle weight rating of 26,001 pounds or more, a vehicle designed to carry 16 or more people including the driver, or any vehicle of any size used to transport placarded quantities of hazardous materials. Part 382 also lays out the underlying prohibitions — for example, a driver can't refuse a required test and continue operating, and a driver who has a verified positive, refusal, or other rule violation can't be allowed to drive again until they've completed a return-to-duty process under Part 40.

Employers and industries outside this federally regulated scope — most retail, office, hospitality, and general private-sector jobs — set their own policies, which may or may not mirror the federal model. If you don't know whether your job is DOT-regulated, your employer's HR or safety office can tell you directly; it typically comes down to the kind of vehicle, equipment, or operation involved.

The testing process, briefly

Federally regulated programs run on a two-step model. Specimens go through an initial screening test, typically an immunoassay, and anything that screens positive goes to a second, independent confirmatory test — gas chromatography–mass spectrometry or liquid chromatography–tandem mass spectrometry — before it can be reported as positive. Updated HHS Mandatory Guidelines for urine testing became effective February 1, 2024, and companion guidelines for oral fluid testing became effective October 10, 2023 (HHS/SAMHSA, Mandatory Guidelines for Federal Workplace Drug Testing Programs, Federal Register, October 12, 2023). Hair testing has been proposed but is not yet part of the federal program.

What a Medical Review Officer is and does

A Medical Review Officer, or MRO, is a licensed physician with specific training and qualification requirements who serves as an independent, impartial reviewer of laboratory drug test results in regulated testing programs (49 CFR Part 40, Subpart G). The MRO's job is not to decide whether someone gets to keep their job — that decision belongs to the employer. The MRO's job is narrower and specific: review the laboratory's confirmed result, check the paperwork for any error that would require canceling the test, and — for any non-negative laboratory result — give the individual a confidential opportunity to provide a legitimate medical explanation before the result is ever reported to the employer.

If there's a legitimate explanation — a valid prescription that accounts for a positive result, for example — the MRO reports the result as negative to the employer. If there isn't, the MRO verifies it as positive (or otherwise non-negative) and reports that. Under the updated federal guidelines, MROs also carry expanded reporting obligations, including periodic reports on specimens that laboratories flagged as positive but that the MRO ultimately verified as negative, which is part of how the federal system tracks its own accuracy over time (HHS/SAMHSA, 2023 Federal Register notice, cited above).

What "non-negative" actually means

"Non-negative" is regulatory language, and it's broader than most people assume. Under federal definitions, a specimen is reported as non-negative if it comes back positive, adulterated, substituted, or invalid — four distinct outcomes lumped under one label because they all require the same next step: MRO review before anything is finalized.

Positive means a drug or metabolite was confirmed at or above the cutoff.
Adulterated means the specimen shows evidence of a foreign substance that isn't consistent with normal human specimen composition.
Substituted means the specimen's characteristics are inconsistent with a genuine human specimen of that type altogether.
Invalid means the lab found a physical or chemical inconsistency that prevented it from completing testing at all, without necessarily pointing to substitution or adulteration.

None of these outcomes are final until an MRO has reviewed the case. A "non-negative" laboratory finding is the start of the verification process, not the end of it — which is exactly why the MRO step exists.

Why this all matters for you

The category of test you're facing changes what to expect procedurally, but it doesn't change the underlying chemistry: what shows up in a specimen depends on what you've used, how recently, how often, and which specimen type is being tested (urine, oral fluid, hair, or blood each answer a different question — see our companion articles on each). If a specific result or process question is on the table for your own situation, your employer's testing program administrator or the MRO handling your case is the right first call; for anything with legal stakes, talk to a lawyer licensed where you live.

If your actual goal is cutting back or quitting altogether, our free quiz takes a couple of minutes and gives you a personalized usage tier, an estimated clean-by window, and a taper timeline based on your own pattern of use.

What the research says

This is general information, not medical advice. If you're struggling to stop, talk to a doctor or a counselor. In a crisis in the US, call or text 988. SAMHSA's free helpline is 1-800-662-4357.